Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials.
Hauser RA, Kremens DE, Elmer LW, Kreitzman DL, Walsh RR, Johnson R, Howard R, Nguyen JT, Patni R. Hauser RA, et al. Among authors: kreitzman dl. J Parkinsons Dis. 2019;9(3):591-600. doi: 10.3233/JPD-181565. J Parkinsons Dis. 2019. PMID: 31081793 Free PMC article. Clinical Trial.
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease.
Tetrud J, Nausieda P, Kreitzman D, Liang GS, Nieves A, Duker AP, Hauser RA, Farbman ES, Ellenbogen A, Hsu A, Kell S, Khanna S, Rubens R, Gupta S. Tetrud J, et al. J Neurol Sci. 2017 Feb 15;373:116-123. doi: 10.1016/j.jns.2016.11.047. Epub 2016 Nov 23. J Neurol Sci. 2017. PMID: 28131167 Free article. Clinical Trial.
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.
Olanow CW, Kieburtz K, Leinonen M, Elmer L, Giladi N, Hauser RA, Klepiskaya OS, Kreitzman DL, Lew MF, Russell DS, Kadosh S, Litman P, Friedman H, Linvah N, The P B Study Group F. Olanow CW, et al. Among authors: kreitzman dl. Mov Disord. 2017 May;32(5):783-789. doi: 10.1002/mds.26941. Epub 2017 Apr 3. Mov Disord. 2017. PMID: 28370340 Clinical Trial.
Expert Consensus on the Use of On-Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel.
Isaacson SH, Achari M, Bhidayasiri R, Comella C, Farmer JG, Gupta F, Jones S, Kreitzman D, Kremens D, Lewis SJG, Poewe W, Tolosa E, Campos C, Gibbs SN, Broder MS. Isaacson SH, et al. Mov Disord Clin Pract. 2023 Mar 11;10(4):652-657. doi: 10.1002/mdc3.13690. eCollection 2023 Apr. Mov Disord Clin Pract. 2023. PMID: 37070052 Free PMC article.
A Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Release Pramipexole in Early Parkinson's Disease.
Olanow CW, Hauser RA, Burdick DJ, Dhall R, de Marcaida JA, Gil RA, Kreitzman DL, Elmer LW, McGarry A, Kieburtz K; P2B Study Group. Olanow CW, et al. Among authors: kreitzman dl. Mov Disord. 2024 Feb;39(2):350-359. doi: 10.1002/mds.29642. Epub 2023 Oct 27. Mov Disord. 2024. PMID: 37886872 Clinical Trial.
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis.
Ballard CG, Kreitzman DL, Isaacson S, Liu IY, Norton JC, Demos G, Fernandez HH, Ilic TV, Azulay JP, Ferreira JJ, Abler V, Stankovic S; 015 Study Group. Ballard CG, et al. Among authors: kreitzman dl. Parkinsonism Relat Disord. 2020 Aug;77:100-106. doi: 10.1016/j.parkreldis.2020.06.026. Epub 2020 Jun 28. Parkinsonism Relat Disord. 2020. PMID: 32712560
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients.
Isaacson SH, Ballard CG, Kreitzman DL, Coate B, Norton JC, Fernandez HH, Ilic TV, Azulay JP, Ferreira JJ, Abler V, Stankovic S; 015 Study Group. Isaacson SH, et al. Among authors: kreitzman dl. Parkinsonism Relat Disord. 2021 Jun;87:25-31. doi: 10.1016/j.parkreldis.2021.04.012. Epub 2021 Apr 28. Parkinsonism Relat Disord. 2021. PMID: 33933853 Free article. Clinical Trial.
Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study.
Isaacson SH, Boroojerdi B, Waln O, McGraw M, Kreitzman DL, Klos K, Revilla FJ, Heldman D, Phillips M, Terricabras D, Markowitz M, Woltering F, Carson S, Truong D. Isaacson SH, et al. Among authors: kreitzman dl. Parkinsonism Relat Disord. 2019 Jul;64:132-137. doi: 10.1016/j.parkreldis.2019.01.025. Epub 2019 Jan 28. Parkinsonism Relat Disord. 2019. PMID: 30948242 Clinical Trial.
Cerebral foreign body.
Kreitzman D, Knorr J. Kreitzman D, et al. Arch Neurol. 2003 Nov;60(11):1640. doi: 10.1001/archneur.60.11.1640. Arch Neurol. 2003. PMID: 14623740 No abstract available.
11 results